BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 26921826)

  • 1. PBT assessment and prioritization of contaminants of emerging concern: Pharmaceuticals.
    Sangion A; Gramatica P
    Environ Res; 2016 May; 147():297-306. PubMed ID: 26921826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBT assessment and prioritization by PBT Index and consensus modeling: comparison of screening results from structural models.
    Gramatica P; Cassani S; Sangion A
    Environ Int; 2015 Apr; 77():25-34. PubMed ID: 25617903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.
    Ortiz de García S; Pinto GP; García-Encina PA; Irusta Mata RI
    J Environ Manage; 2013 Nov; 129():384-97. PubMed ID: 23995140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hazard of pharmaceuticals for aquatic environment: Prioritization by structural approaches and prediction of ecotoxicity.
    Sangion A; Gramatica P
    Environ Int; 2016 Oct; 95():131-43. PubMed ID: 27568576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Pharmaceuticals on the Environment: Risk Assessment Using QSAR Modeling Approach.
    Kar S; Roy K; Leszczynski J
    Methods Mol Biol; 2018; 1800():395-443. PubMed ID: 29934904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are some "safer alternatives" hazardous as PBTs? The case study of new flame retardants.
    Gramatica P; Cassani S; Sangion A
    J Hazard Mater; 2016 Apr; 306():237-246. PubMed ID: 26742016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Greener chemicals for the future: QSAR modelling of the PBT index using ETA descriptors.
    De P; Roy K
    SAR QSAR Environ Res; 2018 Apr; 29(4):319-337. PubMed ID: 29457543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for PBT chemicals among the "existing" and "new" chemicals of the EU.
    Strempel S; Scheringer M; Ng CA; Hungerbühler K
    Environ Sci Technol; 2012 Jun; 46(11):5680-7. PubMed ID: 22494215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment for ecotoxicity of pharmaceuticals--an emerging issue.
    Kar S; Roy K
    Expert Opin Drug Saf; 2012 Mar; 11(2):235-74. PubMed ID: 22166011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated in silico strategy for PBT assessment and prioritization under REACH.
    Pizzo F; Lombardo A; Manganaro A; Cappelli CI; Petoumenou MI; Albanese F; Roncaglioni A; Brandt M; Benfenati E
    Environ Res; 2016 Nov; 151():478-492. PubMed ID: 27567352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental risk analysis and prioritization of pharmaceuticals in a developing world context.
    Mansour F; Al-Hindi M; Saad W; Salam D
    Sci Total Environ; 2016 Jul; 557-558():31-43. PubMed ID: 26994791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation.
    Besse JP; Garric J
    Toxicol Lett; 2008 Jan; 176(2):104-23. PubMed ID: 18077113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR modeling of cumulative environmental end-points for the prioritization of hazardous chemicals.
    Gramatica P; Papa E; Sangion A
    Environ Sci Process Impacts; 2018 Jan; 20(1):38-47. PubMed ID: 29226926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus QSAR modeling of toxicity of pharmaceuticals to different aquatic organisms: Ranking and prioritization of the DrugBank database compounds.
    Khan K; Benfenati E; Roy K
    Ecotoxicol Environ Saf; 2019 Jan; 168():287-297. PubMed ID: 30390527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental risk assessment of selected organic chemicals based on TOC test and QSAR estimation models.
    Chi Y; Zhang H; Huang Q; Lin Y; Ye G; Zhu H; Dong S
    J Environ Sci (China); 2018 Feb; 64():23-31. PubMed ID: 29478644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of human biotransformation QSARs and application for PBT assessment refinement.
    Papa E; Sangion A; Arnot JA; Gramatica P
    Food Chem Toxicol; 2018 Feb; 112():535-543. PubMed ID: 28412404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative survey of chemistry-driven in silico methods to identify hazardous substances under REACH.
    Nendza M; Gabbert S; Kühne R; Lombardo A; Roncaglioni A; Benfenati E; Benigni R; Bossa C; Strempel S; Scheringer M; Fernández A; Rallo R; Giralt F; Dimitrov S; Mekenyan O; Bringezu F; Schüürmann G
    Regul Toxicol Pharmacol; 2013 Aug; 66(3):301-14. PubMed ID: 23707536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction to special series: science-based guidance and framework for the evaluation and identification of PBTs and POPs.
    Klecka GM; Muir DC; Dohmen P; Eisenreich SJ; Gobas FA; Jones KC; Mackay D; Tarazona JV; van Wijk D
    Integr Environ Assess Manag; 2009 Oct; 5(4):535-8. PubMed ID: 19552505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling exposure to persistent chemicals in hazard and risk assessment.
    Cowan-Ellsberry CE; McLachlan MS; Arnot JA; Macleod M; McKone TE; Wania F
    Integr Environ Assess Manag; 2009 Oct; 5(4):662-79. PubMed ID: 19552503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.